Cargando…

Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus

Patients with the multiple endocrine neoplasia type 1 (MEN1) syndrome carry germline heterozygous loss-of-function mutations in the MEN1 gene which predisposes them to develop various endocrine and non-endocrine tumors. Over 90% of the tumors show loss of heterozygosity (LOH) at chromosome 11q13, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandl, Adel, Welch, James M, Kapoor, Gayathri, Parekh, Vaishali I, Schrump, David S, Ripley, R Taylor, Walter, Mary F, Del Rivero, Jaydira, Jha, Smita, Simonds, William F, Jensen, Robert T, Weinstein, Lee S, Blau, Jenny E, Agarwal, Sunita K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558845/ https://www.ncbi.nlm.nih.gov/pubmed/34515662 http://dx.doi.org/10.1530/ERC-21-0226

Ejemplares similares

SUN-331 Clinical Characteristics and Genotype-Phenotype Analysis of MEN1 Patients with Thymic Neuroendocrine Tumors
por: Mandl, Adel, et al.
Publicado: (2019)

Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors
por: Ghosh, Raisa, et al.
Publicado: (2022)

MON-320 Lost in the Rugae: High Grade Gastric Neuroendocrine Tumor in an MEN1 Patient with Zollinger-Ellison Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

SAT-310 (18)F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1
por: Tepede, Aisha, et al.
Publicado: (2019)

SUN-124 Are Venous Thromboembolic Events Increased in MEN1 Patients?
por: Lee, Maya E, et al.
Publicado: (2020)

SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020)

SUN-128 Impaired Fasting Glucose Is Associated with Insulin Resistance in Patients with Germline Mutations in the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
por: Bansal, Rashika, et al.
Publicado: (2020)

SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors
por: Jha, Smita, et al.
Publicado: (2023)

MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1
por: Kamilaris, Crystal, et al.
Publicado: (2019)

In Reply to Loh and Lin:
por: Vaduganathan, Muthiah, et al.
Publicado: (2014)

SAT-LB060 Clinical Presentation and Management of Primary Ovarian Carcinoids in Multiple Endocrine Neoplasia Type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

MON-LB055 A Single Center Experience of Multiple Endocrine Neoplasia Type 1 (MEN1) vs Sporadic Insulinoma: What Can We Learn and Where Are We Going?
por: Itatani, Miho, et al.
Publicado: (2019)

Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer
por: Kotake, Masanori, et al.
Publicado: (2021)

Vitamin B6 Deficiency Promotes Loss of Heterozygosity (LOH) at the Drosophila warts (wts) Locus
por: Gnocchini, Eleonora, et al.
Publicado: (2022)

LBSAT144 Single-center Experience With Hyperparathyroidism-jaw Tumor Syndrome - Where Do We Stand?
por: Tora, Rana S, et al.
Publicado: (2022)

Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH
por: Garcia-Linares, Carles, et al.
Publicado: (2011)

FRI686 Phenotypic Profiling And Molecular Mechanisms In Hyperparathyroidism-jaw Tumor Syndrome
por: Tora, Rana, et al.
Publicado: (2023)

Life Origination Hydrate Hypothesis (LOH-Hypothesis)
por: Ostrovskii, Victor, et al.
Publicado: (2012)

An integrated Bayesian analysis of LOH and copy number data
por: Rancoita, Paola MV, et al.
Publicado: (2010)

2022 ISCB Overton Prize: Po-Ru Loh
por: Fogg, Christina, et al.
Publicado: (2022)

Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection
por: Li, Xiaohong, et al.
Publicado: (2007)

SAT556 An Unusual Case of Papillary Thyroid Carcinoma With Biallelic MEN1 Variants In a Patient With MEN1
por: Chuki, Elias, et al.
Publicado: (2023)

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
por: Hügel, A, et al.
Publicado: (1999)

Darwinian rebel: The legacy of Loh-Seng Tsai—Chinese animal psychologist
por: Wang, Yong, et al.
Publicado: (2021)

OR23-06 Long Term Outcomes Of Parathyroid Autografts In Primary Hyperparathyroidism
por: Chuki, Elias, et al.
Publicado: (2023)

Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women
por: Chambuso, Ramadhani, et al.
Publicado: (2019)

Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer
por: ELTAHIR, HUDA A., et al.
Publicado: (2012)

Erratum to clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients
Publicado: (2021)

LOH at 3p correlates with a poor survival in oral squamous cell carcinoma.
por: Partridge, M., et al.
Publicado: (1996)

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
por: Hawthorn, Lesleyann, et al.
Publicado: (2010)

Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions
por: Wang, Yu, et al.
Publicado: (2015)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy
por: Zhang, Xiaotao, et al.
Publicado: (2022)

Bias and discrimination against men with overweight in the military
por: Christian, Andrew, et al.
Publicado: (2020)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_ilosneoqmf1tr6quv3177ba69k